Among these genes, ANXA2R (Annexin A2 Receptor), RBM3 (RNA-binding Protein 3), and SUCLG2 (Succinyl-CoA ligase [GDP-forming] subunit β), which may act as cancer drivers, were downregulated. This evidence concerns the gene ANXA2R and cancer.